These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 32624192)
21. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus. Jakhar D; Kaur I Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358 [No Abstract] [Full Text] [Related]
22. Chloroquine and COVID-19: A western medical and scientific drift? Million M; Roussel Y; Raoult D Eur J Intern Med; 2020 Aug; 78():4-5. PubMed ID: 32600860 [No Abstract] [Full Text] [Related]
23. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings. Islam M J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461 [No Abstract] [Full Text] [Related]
24. Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes. Funck-Brentano C; Salem JE; Nguyen LS; Drici MD; Roden DM Arch Cardiovasc Dis; 2020 May; 113(5):367-368. PubMed ID: 32331979 [No Abstract] [Full Text] [Related]
25. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895 [TBL] [Abstract][Full Text] [Related]
26. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Yazdany J; Kim AHJ Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419 [TBL] [Abstract][Full Text] [Related]
27. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals. Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586 [TBL] [Abstract][Full Text] [Related]
28. Chloroquine and hydroxychloroquine in covid-19. Ferner RE; Aronson JK BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046 [No Abstract] [Full Text] [Related]
29. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Uzunova K; Filipova E; Pavlova V; Vekov T Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965 [TBL] [Abstract][Full Text] [Related]
30. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out. De Franceschi L; Costa E; Dima F; Morandi M; Olivieri O Eur J Intern Med; 2020 Oct; 80():103. PubMed ID: 32819797 [No Abstract] [Full Text] [Related]
31. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings. Mvumbi DM Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009 [No Abstract] [Full Text] [Related]
32. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic]. Bozzo R; Ibelli F; Scublinsky D Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855 [No Abstract] [Full Text] [Related]
33. Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Miller MC; Abraham GM; Obley AJ; Forciea MA; Jokela JA; Humphrey LL; Ann Intern Med; 2020 Jul; 173(2):W48-W51. PubMed ID: 32551892 [No Abstract] [Full Text] [Related]
34. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105 [No Abstract] [Full Text] [Related]
35. The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials. Malviya A Int J Infect Dis; 2020 Oct; 99():310-311. PubMed ID: 32738490 [No Abstract] [Full Text] [Related]
36. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618 [TBL] [Abstract][Full Text] [Related]
37. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19. Fassihi SC; Nabar NR; Fassihi R Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278 [No Abstract] [Full Text] [Related]
38. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials. Shittu MO; Afolami OI Infez Med; 2020 Ahead of print Jun 1; 28(2):192-197. PubMed ID: 32335560 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
40. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus. de Miranda Santos IKF; Costa CHN Front Immunol; 2020; 11():1739. PubMed ID: 32849619 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]